Explore comprehensive CDMO and CRO services offered by Evitria AG, supporting end-to-end Drug Development. Evitria AG enables faster, compliant, and scalable pharma innovation tailored to your needs.
Country: Switzerland
Description: Evitria AG is a leading Swiss-based Contract Research Organization (CRO) specializing in rapid, high-quality recombinant antibody and protein production using CHO (Chinese Hamster Ovary) cell transient expression, serving biotech, pharma, and academia globally with services for standard, bispecific, and engineered antibodies (like afucosylated/Fc-silenced) from small mg to multi-gram scales, focusing on speed (often <5 weeks) and quality for discovery/preclinical needs.
